Care Management for Serious Mental Illness: A Systematic Review and Meta-Analysis

2021 ◽  
pp. appi.ps.2020004
Author(s):  
Christopher T. Lim ◽  
Marissa P. Caan ◽  
Clara H. Kim ◽  
Clifton M. Chow ◽  
H. Stephen Leff ◽  
...  
Keyword(s):  
Systematic Review ◽  
Mental Illness ◽  
Serious Mental Illness ◽  
Care Management ◽  
Meta Analysis

scholarly journals Lifestyle interventions for weight loss among overweight and obese adults with serious mental illness: A systematic review and meta-analysis

2017 ◽  
Vol 47 ◽  
pp. 83-102 ◽  
Author(s):  
John A. Naslund ◽  
Karen L. Whiteman ◽  
Gregory J. McHugo ◽  
Kelly A. Aschbrenner ◽  
Lisa A. Marsch ◽  
...  
Keyword(s):  
Systematic Review ◽  
Mental Illness ◽  
Weight Loss ◽  
Serious Mental Illness ◽  
Meta Analysis ◽  
Lifestyle Interventions ◽  
Obese Adults

scholarly journals Pharmacological and behavioural interventions to promote smoking cessation in adults with schizophrenia and bipolar disorders: a systematic review and meta-analysis of randomised trials

BMJ Open ◽  
2019 ◽  
Vol 9 (11) ◽  
pp. e027389 ◽  
Author(s):  
Robert Pearsall ◽  
Daniel J Smith ◽  
John R Geddes
Keyword(s):  
Systematic Review ◽  
Mental Illness ◽  
Smoking Cessation ◽  
Serious Mental Illness ◽  
Randomised Controlled Trials ◽  
Meta Analysis ◽  
Public Health Problem ◽  
Controlled Trials ◽  
Major Public Health Problem ◽  
Randomised Controlled

ObjectiveSmoking in people with serious mental illness is a major public health problem and contributes to significant levels of morbidity and mortality. The aim of the review was to systematically examine the efficacy of methods used to aid smoking cessation in people with serious mental illness.MethodA systematic review and meta-analysis of randomised controlled trials to compare the effectiveness and safety of pharmacological and behavioural programmes for smoking cessation in people with serious mental illness. Electronic databases were searched for trials to July 2018. We used the Cochrane Collaboration’s tool for assessing the risk of bias.ResultsTwenty-eight randomised controlled trials were identified. Varenicline increased the likelihood of smoking cessation at both 3 months (risk ratio (RR) 3.56, 95% CI 1.82 to 6.96, p=0.0002) and at 6 months (RR 3.69, 95% CI 1.08 to 12.60, p=0.04). Bupropion was effective at 3 months (RR 3.96, 95% CI 1.86 to 8.40, p=0.0003), especially at a dose of 300 mg/day, but there was no evidence of effect at 6 months (RR 2.22, 95% CI 0.52 to 9.47, p=0.28). In one small study, nicotine therapy proved effective at increasing smoking cessation up to a period of 3 months. Bupropion used in conjunction with nicotine replacement therapy showed more effect than single use. Behavioural and bespoke interventions showed little overall benefit. Side effects were found to be low.ConclusionThe new information of this review was the effectiveness of varenicline for smoking cessation at both 3 and 6 months and the lack of evidence to support the use of both bupropion and nicotine products for sustained abstinence longer than 3 months. Overall, the review found relatively few studies in this population.

scholarly journals Exercise therapy in adults with serious mental illness: a systematic review and meta-analysis

2014 ◽  
Vol 14 (1) ◽  
Author(s):  
Robert Pearsall ◽  
Daniel J Smith ◽  
Anthony Pelosi ◽  
John Geddes
Keyword(s):  
Systematic Review ◽  
Mental Illness ◽  
Serious Mental Illness ◽  
Exercise Therapy ◽  
Meta Analysis

scholarly journals Oral health self‐care behaviours in serious mental illness: A systematic review and meta‐analysis

2021 ◽  
Author(s):  
Elizabeth Turner ◽  
Katherine Berry ◽  
Vishal Aggarwal ◽  
Leah Quinlivan ◽  
Timothy Villanueva ◽  
...  
Keyword(s):  
Systematic Review ◽  
Mental Illness ◽  
Oral Health ◽  
Serious Mental Illness ◽  
Meta Analysis ◽  
Self Care
Sign in / Sign up

Export Citation Format

Share Document